The original UCSF Center for AIDS Research (1988-1993) supported several activities in addition to the core facilities. The most important of these was the awarding of New Investigator Award. After the initial award, we redirected Planning and Evaluation funds to support state-of- the-art Workshops and Symposia. In the final year of the grant, with the limited remaining funds, CFAR funded a small Evolving Research Opportunity proposal. Two of the activities, support for new HIV investigators and support for evolving research opportunities in HIV research, form important components of the newly restricted CFAR. In retrospect, these activities proved to be very important factors in coordinating AIDS research through the CFAR mechanism and in encouraging productive collaborations at UCSF. The current CFAR application requests funds for New Investigator Awards, Pilot Project Awards and Evolving Research Opportunities. Budgetary restrictions preclude plans for Workshops and Symposia similar to those in the original CFAR. However, we have made preliminary plans for a seminar series that would bring basic research and clinical AIDS programs together. The goal of this seminar series is to generate new ideas, foster productive interactions and encourage collaborations between basic research investigators and clinicians across the Campus community. We plan to hold the seminars four times per year in the Gladstone Institute of Virology and Immunology AIDS Research Center Conference Room. Topics currently under consideration include Therapy and Quantification of Viral Load.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027763-08
Application #
5205364
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1996
Total Cost
Indirect Cost
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Scherzer, Rebecca; Shah, Sanjiv J; Secemsky, Eric et al. (2018) Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection. Circ Heart Fail 11:e004312
Shehata, Hesham M; Khan, Shahzada; Chen, Elise et al. (2018) Lack of Sprouty 1 and 2 enhances survival of effector CD8+ T cells and yields more protective memory cells. Proc Natl Acad Sci U S A 115:E8939-E8947
Tang, Eric C; Vittinghoff, Eric; Anderson, Peter L et al. (2018) Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project. J Acquir Immune Defic Syndr 77:193-198
Hosseinipour, Mina C; Kang, Minhee; Krown, Susan E et al. (2018) As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis 67:251-260
Yoon, Christina; Semitala, Fred C; Asege, Lucy et al. (2018) Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV. Am J Respir Crit Care Med :
Tang, Weiming; Liu, Chuncheng; Cao, Bolin et al. (2018) Receiving HIV Serostatus Disclosure from Partners Before Sex: Results from an Online Survey of Chinese Men Who Have Sex with Men. AIDS Behav 22:3826-3835
Ayers, Leona W; Barbachano-Guerrero, Arturo; McAllister, Shane C et al. (2018) Mast Cell Activation and KSHV Infection in Kaposi Sarcoma. Clin Cancer Res 24:5085-5097
Tamraz, Bani; Huang, Yong; French, Audrey L et al. (2018) A Genome-Wide Association Study Identifies a Candidate Gene Associated With Atazanavir Exposure Measured in Hair. Clin Pharmacol Ther 104:949-956
Clutton, Genevieve Tyndale; Jones, R Brad (2018) Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure. Front Immunol 9:1452

Showing the most recent 10 out of 1541 publications